Upgrade to SI Premium - Free Trial

Tango Therapeutics, Inc (TNGX)

32.16 -0.74 (2.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 144 Tango Therapeutics, Inc. Filed by: Beckman Daniella June 11, 2026 6:01 PM - SEC Filing Form 8-K Tango Therapeutics, Inc. For: Jun 09 June 10, 2026 5:22 PM - SEC Filing Form 424B5 Tango Therapeutics, Inc. June 10, 2026 5:21 PM - SEC Filing Form 144 Tango Therapeutics, Inc. Filed by: Beckman Daniella June 10, 2026 4:46 PM - SEC Filing Tango Therapeutics Inc. (TNGX) PT Raised to $66 at H.C. Wainwright June 10, 2026 7:11 AM - StreetInsider Form FWP Tango Therapeutics, Inc. Filed by: Tango Therapeutics, Inc. June 10, 2026 6:03 AM - SEC Filing Tango Therapeutics prices $600 million public offering at $30 per share June 9, 2026 10:49 PM - StreetInsider Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering June 9, 2026 10:49 PM - Globe NewsWire Tango Therapeutics Inc. (TNGX) PT Raised to $35 at B.Riley June 9, 2026 8:28 AM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $42 at Canaccord June 9, 2026 6:50 AM - StreetInsider Form 4 Tango Therapeutics, Inc. For: Jun 05 Filed by: Ketchum John B June 8, 2026 6:08 PM - SEC Filing Form 4 Tango Therapeutics, Inc. For: Jun 05 Filed by: Calhoun Lesley Ann June 8, 2026 6:01 PM - SEC Filing Form 4 Tango Therapeutics, Inc. For: Jun 05 Filed by: Rothenberg Mace June 8, 2026 5:55 PM - SEC Filing Form 4 Tango Therapeutics, Inc. For: Jun 05 Filed by: Lee Sung June 8, 2026 5:49 PM - SEC Filing Form 424B5 Tango Therapeutics, Inc. June 8, 2026 4:16 PM - SEC Filing Tango Therapeutics launches $500 million public stock offering June 8, 2026 4:01 PM - StreetInsider Tango Therapeutics Announces Proposed $500 Million Public Offering June 8, 2026 4:01 PM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $36 at Mizuho June 8, 2026 12:26 PM - StreetInsider Wolfe Research Upgrades Tango Therapeutics Inc. (TNGX) to Outperform, 'Vopi Finds Its Dance Partner' June 8, 2026 11:40 AM - StreetInsider Form 8-K Tango Therapeutics, Inc. For: Jun 08 June 8, 2026 7:16 AM - SEC Filing Tango drug combination shows 92% response rate in pancreatic cancer trial June 8, 2026 7:00 AM - StreetInsider Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer June 8, 2026 6:59 AM - Globe NewsWire Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 5, 2026 7:00 AM - StreetInsider Form 8-K Tango Therapeutics, Inc. For: Jun 04 June 4, 2026 5:19 PM - SEC Filing Form 4 Tango Therapeutics, Inc. For: Jun 01 Filed by: Crystal Adam June 3, 2026 6:37 PM - SEC Filing Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC May 15, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l. May 15, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP May 15, 2026 9:17 AM - SEC Filing Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:34 AM - SEC Filing Piper Sandler Downgrades Tango Therapeutics Inc. (TNGX) to Neutral May 15, 2026 3:10 AM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $30 at Mizuho May 14, 2026 4:13 PM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $55 at Leerink Partners May 14, 2026 2:40 PM - StreetInsider Jefferies Downgrades Tango Therapeutics Inc. (TNGX) to Hold May 14, 2026 2:53 AM - StreetInsider Form 8-K Tango Therapeutics, Inc. For: May 13 May 13, 2026 4:17 PM - SEC Filing Form 10-Q Tango Therapeutics, Inc. For: Mar 31 May 13, 2026 4:16 PM - SEC Filing Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c May 13, 2026 4:08 PM - StreetInsider Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights May 13, 2026 4:07 PM - Globe NewsWire Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P. May 13, 2026 9:18 AM - SEC Filing Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P. May 11, 2026 8:49 AM - SEC Filing Form 8-K Tango Therapeutics, Inc. For: May 07 May 8, 2026 9:22 AM - SEC Filing Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: FMR LLC May 6, 2026 11:41 AM - SEC Filing Form 4 Tango Therapeutics, Inc. For: May 01 Filed by: Crystal Adam May 5, 2026 7:47 PM - SEC Filing Form 4 Tango Therapeutics, Inc. For: May 01 Filed by: Gall Matthew May 5, 2026 7:47 PM - SEC Filing Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 4, 2026 4:31 PM - StreetInsider Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Invus Global Management, LLC May 4, 2026 2:39 PM - SEC Filing Tango Therapeutics, Inc (TNGX) May 23 and 30 calls active, share price up 10% May 4, 2026 2:27 PM - StreetInsider Form 4 Tango Therapeutics, Inc. For: Apr 29 Filed by: Lee Sung May 1, 2026 5:27 PM - SEC Filing Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam May 1, 2026 4:49 PM - SEC Filing Tango Therapeutics, Inc (TNGX) 2900 contracts of June 30 calls trade, share price down 5.5% April 28, 2026 2:37 PM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Stifel on Higher PRMT5 Inhibitor Conviction April 27, 2026 6:04 AM - StreetInsider Form 3 Tango Therapeutics, Inc. For: Apr 15 Filed by: Gall Matthew April 24, 2026 4:15 PM - SEC Filing Form 3 Tango Therapeutics, Inc. For: Apr 15 Filed by: Newcomb Jessica April 24, 2026 4:15 PM - SEC Filing Stifel on Tango Therapeutics Inc. (TNGX): 'We have been consistently bullish' April 20, 2026 12:17 PM - StreetInsider Form ARS Tango Therapeutics, Inc. For: Dec 31 April 17, 2026 7:44 AM - SEC Filing Form DEFA14A Tango Therapeutics, Inc. April 17, 2026 7:42 AM - SEC Filing Form DEF 14A Tango Therapeutics, Inc. For: Apr 16 April 17, 2026 7:12 AM - SEC Filing Form 4 Tango Therapeutics, Inc. For: Apr 15 Filed by: Crystal Adam April 16, 2026 8:14 PM - SEC Filing Form 8-K Tango Therapeutics, Inc. For: Apr 10 April 15, 2026 9:19 AM - SEC Filing Tango Therapeutics names Matthew Gall CFO, adds two executives April 15, 2026 9:05 AM - StreetInsider Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat April 15, 2026 9:05 AM - StreetInsider Tango Therapeutics Inc. (TNGX) PT Raised to $28 at Leerink Partners April 13, 2026 4:09 PM - StreetInsider Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Form 4 Tango Therapeutics, Inc. For: Apr 01 Filed by: Crystal Adam April 2, 2026 8:09 PM - SEC Filing Canaccord Starts Tango Therapeutics Inc. (TNGX) at Buy April 2, 2026 5:12 AM - StreetInsider Form 4 Tango Therapeutics, Inc. For: Mar 25 Filed by: Crystal Adam March 27, 2026 8:07 PM - SEC Filing Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 1:32 PM - SEC Filing Tango Therapeutics Inc. (TNGX) PT Raised to $21 at B.Riley March 27, 2026 4:56 AM - StreetInsider Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam March 25, 2026 4:25 PM - SEC Filing The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology March 19, 2026 11:00 AM - StreetInsider Full Article List